| PERIOD ENDING | 25-Oct-09 | 26-Jul-09 | 26-Apr-09 | 25-Jan-09 | | Total Revenue | 1,675,102 | 1,574,440 | 1,595,043 | 1,689,086 | | Cost of Revenue | 1,370,908 | 1,314,116 | 1,333,005 | 1,416,771 | | | Gross Profit | 304,194 | 260,324 | 262,038 | 272,315 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 142,704 | 142,010 | 139,846 | 142,525 | | Non Recurring |
-
| 674 | (674) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 163,118 | 117,640 | 122,866 | 129,790 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,178 | 6,410 | 8,584 | 2,391 | | Earnings Before Interest And Taxes | 164,332 | 125,014 | 131,546 | 132,085 | | Interest Expense | 6,659 | 6,963 | 6,918 | 7,455 | | Income Before Tax | 157,673 | 118,051 | 124,628 | 124,630 | | Income Tax Expense | 53,797 | 40,882 | 44,243 | 43,247 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 105,504 | 77,169 | 80,385 | 81,383 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 103,876 | 77,169 | 80,385 | 81,383 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $103,876 | $77,169 | $80,385 | $81,383 |
|
0.25% Nasdaq 
0.24%
Income Statement
